JP Patent

JP6683886B2 — 薬物動態が改善された放出調節ガンマ−ヒドロキシ酪酸塩製剤

Assigned to フラメル アイルランド リミテッド · Expires 2020-04-22 · 6y expired

What this patent protects

Patent listed against sodium-oxybate.

Drugs covered by this patent

Patent Metadata

Patent number
JP6683886B2
Jurisdiction
JP
Classification
—
Expires
2020-04-22
Drug substance claim
No
Drug product claim
No
Assignee
フラメル アイルランド リミテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.